Dave Newman

This is my personal account

[Elizabeth Warren @SenWarren]

In America, one health care company can own:

Your doctor
Your pharmacy
Your insurance
AND the middleman between your pharmacy and insurance.

That means more profits for giant companies and higher costs for you.

That's not right — and I have a bill to stop it.

[Meghna Chakrabarti @MeghnaWBUR]

This is so cool.

[Acyn @Acyn]

Tillis: You decided to kill that dog because you had not invested the appropriate time in training it, and then you have the audacity to say it’s a leadership lesson. At that same lunch hour, you killed a goat and said it was behaving badly. You’re a farmer — you don’t castrate a goat, they behave badly. You should have done that before.

[Jeff Huber 🇺🇸 @jhuber]

The NHS-Galleri trial results came out last Friday. 142,000 participants. 3 years. The most ambitious cancer screening trial ever run.

The headlines: primary endpoint missed.

That's a fact, and it matters. But I believe the headlines are missing the deeper story in these data – one that matters enormously to patients and to the future of cancer screening.

Here's what the NHS-Galleri Test study showed:

✅ Stage IV cancer diagnoses – metastatic, typically incurable disease – declined substantially in the screened group, with >20% reductions across the 12 deadliest cancer types

✅ More cancers were found at Stage I & II, when treatment can be curative, in cancers that are typically diagnosed late (pancreatic, ovarian, liver, lung)

✅ 4x higher overall cancer detection rate when Galleri was added to standard screening (i.e., colonoscopy & mammography)

✅ Fewer cancers detected through emergency presentation – the worst possible way to learn you have cancer, and the most lethal and most costly

✅ No serious safety concerns. Test performance consistent with prior studies (with very high 99.5% specificity and very low false positive rate)

So why did the 'primary endpoint' miss? See article for more detail & perspective on the study design, and the 'Stage Migration paradox' that masks enormous progress and clinical impact for patients.

[Rep. Jake Auchincloss 🟧 @RepAuchincloss]

mRNA:
what happened — a COVID vaccine designed in an hour & delivered in months
what’s coming — personalized cancer vaccines
what’s now — a politician at FDA overruling career scientists to cancel the progress

[Cambridge Chamber MA @CambridgeChambr]

The #lifesciences and #biotech industries of #Massachusetts support the US' role as a global leader. We're grateful for policymakers who support #innovation and appreciate the risks of losing that leadership. @RepLoriTrahan

[Prevent Cancer Foundation @preventcancer]

ICYMI: On Friday, the U.S. Senate passed the #MCEDAct! Thank you @MikeCrapo, @SenatorBennet, @SenatorTimScott & @RonWyden for your leadership. It’s now back before the House, who can bring it over the finish line this week. For more info, visit https://t.co/2BpdHuSBH1.

[Prevent Cancer Foundation @preventcancer]

BREAKING: The House has passed the bipartisan #MCEDAct (H.R. 842)! This is a historic step toward Medicare coverage of multi‑cancer early detection tests with the potential to find more cancers earlier for better outcomes. We urge the Senate to act swiftly and pass the bill now!

[New England Council @NECouncil]

The Council is encouraged to see the #MCEDAct included in House Appropriations. This bipartisan bill would expand access to #cancerscreening, enable earlier detection, and help lower healthcare costs. We urge New England’s delegation to support its passage.https://t.co/Nhtq9htwLN

[Lupus Foundation NE @LupusNE]

We’re proud to stand with more than 550 organizations urging Congress to pass the #MCEDAct. @RepRichardNeal, as a strong advocate for this legislation, we encourage you to help push this bill across the finish line.

https://t.co/fjBPAldYYz

[IMPACT Melanoma @IMPACTMelanoma]

With 550+ groups, and 400+ members of Congress, the support is overwhelming. Passing the #MCEDAct NOW would change cancer detection and save lives. The time is now! @RepMcGovern @RepRichardNeal @WhipKClark

[Lupus Foundation NE @LupusNE]

Passage of the #MCEDAct would mark an extraordinary moment in our fight against cancer. The time is now! @RepMcGovern @RepRichardNeal @WhipKClark

[Republicans against Trump @RpsAgainstTrump]

Minneapolis resident: “This is nuts! What the f*ck is going on, this is insane!… I’ve never protested in my life before…ICE is just trying to scare people; they tell you it's only immigrants—it's f*cking anybody!"

[IMPACT Melanoma @IMPACTMelanoma]

Early detection saves lives, and the #MCEDAct can transform how we detect cancer. Proud to stand with @preventcancer and 550+ orgs calling on Congress to act now.

Let’s make 2026 the year we change the future of cancer detection. #CancerPrevention

[Envisioning Access @envisioning541]

We��re proud to stand with more than 550 organizations urging Congress to pass the #MCEDAct. @RepRichardNeal, as a strong advocate for this legislation, we encourage you to help push this bill across the finish line.

[Dave Newman @DENewman]

https://t.co/I6A9iXCag9 #MCED #MCEDAct

[American Cancer Society Cancer Action Network @ACSCAN]

The #MCEDAct hit 400 cosponsors today!

As the most-supported bill in Congress, there's overwhelming bipartisan support to get this important legislation over the finish line. 💪

If passed, it could help innovative cancer #EarlyDetection tests reach more people who need them.

[Dave Newman @DENewman]

https://t.co/0qvU5XyvJ1

[American Cancer Society Cancer Action Network @ACSCAN]

#EarlyDetection can improve access to cancer screenings, health outcomes, and bend the curve on the cost of health care—all of which can save more lives. That’s why it’s critical for Congress to get the #MCEDAct over the finish line before the end of this year. (1/3)

[American Cancer Society Cancer Action Network @ACSCAN]

Tomorrow, our cancer advocates will attend the @HouseCommerce @EnergyCommerce Subcommittee on Health to push for more support of the #MCEDAct. #CancerLobbyDay (2/2)